OPIATE‐LIKE ANALGESIC ACTIVITY IN GENERAL ANAESTHETICS
OPIATE‐LIKE ANALGESIC ACTIVITY IN GENERAL ANAESTHETICS
复制标题
全身麻醉中的阿片类镇痛活性
DOI:
--
复制
发表时间:
1981
影响因子:
7.3
通讯作者:
A. Livingston
中科院分区:
文献类型:
--
作者:
D. Lawrence;A. Livingston
1 The interaction of naloxone with various anaesthetics was studied both in vivo and in vitro. 2 Naloxone (10 mg/kg) did not significantly alter the anaesthetic duration of halothane, diethylether, ketamine, pentobarbitone or Althesin. 3 Naloxone (10 mg/kg) reduced the analgesic activity of nitrous oxide, ketamine and morphine in the rat tail‐flick test. With the exception of pentobarbitone and Althesin, the other anaesthetic agents also induced analgesia but were not antagonized by naloxone. 4 Specific [3H]‐dihydromorphine binding was displaced by the opiates naloxone (IC50=7.6nM), methionine‐enkephalin (Met‐enkephalin, IC50=40nM) and morphine (IC50=54nM). Similarly, displacement was observed with xylazine (IC50=9μ,m), ketamine (IC50 = 130μm) and Althesin (IC50 = 150 μm); other anaesthetics agents tested were inactive in mM concentrations. 5 Ketamine (IC50 =200 μm) and xylazine (IC50 =9.5 μ,m) were also capable of displacing specific [3H]‐D‐Ala2‐enkephalin (D‐Leu) binding, as were morphine (IC50 = 95 nM) and Met‐enkephalin (IC50 = 40nM). 6 On the stimulated guinea‐pig ileum, Met‐enkephalin and morphine inhibited the contractions, the IC50 values were 30 nM and 50 nM respectively. The anaesthetics ketamine (IC50 = 10μm) and Althesin (IC50 = 8μ,m) were active. Xylazine (IC50 = 12nM) exhibited considerable potency in inhibiting the contractions on this preparation. Naloxone 0.5 μ,M produced a 1000 fold shift in the opiate dose‐response curve but the anaesthetic responses showed only slight sensitivity to antagonism by naloxone. 7 The activity of Althesin was found to be due to the vehicle in which this anaesthetic is solubilised. 8 Whilst several anaesthetic agents showed analgesic activity, specific dihydromorphine binding displacement or guinea pig ileum inhibiting activity, these effects showed variable sensitivity to naloxone.